(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

CONTROLE DA DISBIOSE MICROBIANA COM TEMOCILINA

Em ExigênciaInvention PatentPCT · US2020066656

Application data

Number

112022012451

Type

Invention Patent

Filing

12/22/2020

Publication

09/06/2022

PCT

US2020066656

Progress at the INPI

Technical opinion to answer
  1. Filing12/22/20
  2. Publication09/06/22
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 05/19/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

ENTASIS THERAPEUTICS, INC.

US

Inventors

A. S. (pessoa física)

US

R. I. (pessoa física)

US

S. M. (pessoa física)

US

Technical data

Priority claims

US

62/952,874 · 12/23/2019

US

62/958,979 · 01/09/2020

Abstract

A presente invenção refere-se a métodos de uso de temocilina para controlar a disbiose microbiana decorrente, em certos casos, do supercrescimento de enterobactérias, tal como o supercrescimento de E. coli aderente-invasiva (AIEC). Os métodos de uso de temocilina para tratar distúrbios intestinais e seus sintomas causados pela disbiose microbiana, bem como outros distúrbios, estão contemplados neste documento.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Parecer de pré-exame

#6.23

05/19/2026

RPI 2889

Notificação de entrada na fase nacional - PCT

#1.3

09/06/2022

RPI 2696

Alteração de dados cadastrais

#1.1

07/05/2022

RPI 2687

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.